We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » European Medical Group Questions Remdesivir Use for COVID-19 Patients
European Medical Group Questions Remdesivir Use for COVID-19 Patients
Despite the FDA’s recent approval, international skepticism persists over the use of Gilead Sciences’ remdesivir for treating COVID-19 patients. Another prominent group, the European Society of Intensive Care Medicine, is now advising clinicians that the drug should not be routinely used for treating COVID-19 patients